Rosuvastatin Calcium (Crestor®) Simvastatin (Zocor®) Other medications used to treat high cholesterol include: Ezetimibe (Zetia®), a cholesterol absorption inhibitor and the most commonly used non-statin cholesterol medication ACL inhibitors such as bempedoic acid (Nexletol®), which target ...
TheJUPITER trialrandomized 17.800 middle-aged to elderly individuals at intermediate or low-risk to treatment with rosuvastatin (a cholesterol lowering drug) or placebo. Patients selected for the study had to have hs-CRP > 2mg/l, and LDL-C < 130 mg/dl (3.37 mmol/l). Rosuvastatin significant...
to calculate relative signal intensities (e.g. compared to sternocleidomastoid muscle) gives rise to high intra/inter-observer variability [48]. This is mainly due to the strong influence of spatial variations in coil sensitivity on relative signal intensity, as well as the specific choice of MR...
Until a definitive cure is found, patients can benefit from adopting a diet rich in complex carbohydrates and ingesting simple carbohydrates before strenuous exercise Carefully supervised, regular, aerobic exercise of low to moderate intensity is a safe, recommended therapeutic option, but exercises that...
Abstract Persistently positive antiphospholipid antibodies (aPL) in association with thromboses and/or pregnancy morbidity is the hallmark of the antiphospholipid syndrome (APS). The management of aPL-positive patients has been focused on utilizing traditional antithrombotic medications, such as heparin or ...
29. Schuster H. The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk. Expert Rev Cardiovasc Ther. 2007 Mar:5(2):177-93. 30. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of very high-intensity statin therapy on ...
The GALAXY Program: an update on studies investigating efficacy and tolerability of rosuvastatin for reducing cardiovascular risk. Expert Rev Cardiovasc Ther. 2007 Mar:5(2):177-93. 30. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of very high-intensity statin therapy on regression of ...
The combination of ezetimibe and rosuvastatin was postulated as a treatment that could lead to hepatic steatosis reduction, which was proved by Cho et al. in a study which introduced this kind of treatment into patients for 24 weeks. Moreover, it was proven that the combination of these two ...
Furthermore, the maximal dose of rosuvastatin at 40 mg/day appears to increase the catabolism of LDL- ApoB100 without affecting ApoB100 PR in a dose-related manner [122]. In the STELLAR clinical trial, rosuvastatin at doses ranging from 10 mg to 40 mg was reported to be superior ...